Given that most cancer-associated POT1 mutations are likely to result in a loss of function, the inhibition of POT1 might not be a useful therapeutic strategy, but an analysis of the genetic dependencies of POT1 mutant cancer cells may suggest an effective synthetic-lethal approach to treatment. This evidence concerns the gene POT1 and cancer.